Cencora Specialty Distribution has been named as one of four national wholesalers for AOP Health’s newly FDA-approved Rapiblyk™ (landiolol), enabling hospitals and health systems to access the ultra-short-acting beta-blocker through Cencora’s specialty channels. This addition could bolster COR’s specialty product revenues and expand its critical-care therapy portfolio.